@article{279f7ee0f0e3492da6aaa33c507fb5d2,
title = "Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy",
keywords = "BTK inhibitor, Mantle cell lymphoma (MCL), brexucabtagene autoleucel, chimeric antigen receptor therapy, ibrutinib, non-Hodgkin lymphoma, venetoclax",
author = "Preetesh Jain and Loretta Nastoupil and Jason Westin and Lee, {Hun Ju} and Lucy Navsaria and Steiner, {Raphael E.} and Sairah Ahmed and Omar Moghrabi and Onyeka Oriabure and Wendy Chen and Maria Badillo and Flowers, {Christopher R.} and Wang, {Michael L.}",
year = "2021",
month = jan,
doi = "10.1111/bjh.17197",
language = "English (US)",
volume = "192",
pages = "e38--e42",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",
}